Arvinas (ARVN) Retained Earnings (2017 - 2026)
Arvinas' (ARVN) quarterly Retained Earnings came in at $2.1 billion in Q1 2026, up 143166.67% year-on-year from N/an in Q1 2025, and up 178983.33% quarter-over-quarter from $1.2 million in Q4 2025.
Arvinas (ARVN) Retained Earnings (2017 - 2026) Analysis & Trends
Arvinas' Retained Earnings history runs 10 years deep, the most recent figure standing at $2.1 billion for Q1 2026.
- On a quarterly basis, Retained Earnings rose 143166.67% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $2.1 billion, a 143166.67% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 100.08% from the prior year.
- Retained Earnings advanced to $2.1 billion in Q1 2026 per ARVN's latest filing, from $1.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at $2.1 billion in Q1 2026 and bottomed at -$1.5 billion in Q4 2024.
- The 5-year median for Retained Earnings is $1.2 million (2025), against an average of $337.7 million.
- Biggest YoY gain for Retained Earnings was 310205.56% in 2022; the steepest drop was 317.39% in 2022.
- Year by year, Retained Earnings stood at -$19.2 million in 2022, then soared by 10494.27% to $2.0 billion in 2023, then sank by 176.75% to -$1.5 billion in 2024, then soared by 100.08% to $1.2 million in 2025, then jumped by 178983.33% to $2.1 billion in 2026.
- Per Business Quant, the three latest ARVN Retained Earnings figures stand at $2.1 billion (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -622,000.00 |
| 10 | Arvinas | 512.64 Mn | -102.26 Mn | - | 2.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.15 Bn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 2.12 Bn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | -1.53 Bn |
| Sep 30, 2024 | 2.07 Bn |
| Jun 30, 2024 | -1.44 Bn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | 2.00 Bn |
| Sep 30, 2023 | 1.64 Bn |
| Jun 30, 2023 | -1.11 Bn |
| Mar 31, 2023 | -12.60 Mn |
| Dec 31, 2022 | -19.20 Mn |
| Sep 30, 2022 | -882.50 Mn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | -746.30 Mn |
| Dec 31, 2021 | -4.60 Mn |
| Sep 30, 2021 | 1.45 Bn |
| Jun 30, 2021 | -486,544.00 |